Halper Sadeh Investigates Varonis Systems' $49.75-Per-Share Cash Sale to Proofpoint

Halper Sadeh LLC is investigating whether Varonis Systems, Inc. is obtaining a fair price in its proposed $49.75-per-share cash sale to Proofpoint, Inc. The investor rights law firm announced the probe on October 15, 2026, according to Business Wire. Varonis trades on the Nasdaq under the ticker VRNS.

Halper Sadeh Questions the Varonis Sales Process

The investigation concerns whether Varonis and its board of directors violated federal securities laws or breached their fiduciary duties by failing to obtain the best possible price for shareholders, conduct a fair sales process free of conflicts of interest, and disclose all material information shareholders need to evaluate the transaction. Halper Sadeh said insiders may stand to receive substantial financial benefits not available to ordinary shareholders, and that the proposed transaction may contain terms that could limit superior competing offers. "We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses," the firm said. Halper Sadeh may seek increased consideration, additional disclosures, or other relief and benefits on behalf of shareholders. The firm encourages Varonis shareholders to contact Daniel Sadeh or Zachary Halper at no cost or obligation.

Halper Sadeh's Contingency-Fee Practice

Halper Sadeh LLC is a New York-based contingency-fee investor rights law firm that represents defrauded shareholders in securities class actions, derivative suits and M&A fairness investigations, according to akta.pro company records. The firm was founded in 2015 by Zachary Halper and Daniel Sadeh, and it has recovered millions of dollars for defrauded investors. Those recoveries include $20 million in In re Galena Biopharma, Inc., Securities Litigation and $23.5 million in Thomas v. Magnachip Semiconductor Corp. In 2025 the firm launched a free portfolio monitoring service that notifies clients of market losses potentially caused by corporate fraud and assists with claim form filings.

Halper Sadeh's Recent Investigation Alerts

Halper Sadeh has issued a series of similar M&A fairness alerts in recent months. On August 24, 2026, the firm said it was investigating Werewolf Therapeutics, Beazer Homes USA, MarketAxess Holdings and CBIZ for potential securities law violations and fiduciary duty breaches, according to FinancialContent Business Page. On August 28, 2026, it announced investigations into four companies, including VREX and NATH, on the same grounds. On September 8, 2026, the firm said it was investigating Bio-Techne's sale to Merck, Colony Bankcorp's merger with First Reliance, and Auddia's merger with Thramann.

What Comes Next for Varonis Shareholders

Varonis shareholders can contact Halper Sadeh free of charge at (212) 763-0060 or by email at sadeh@halpersadeh.com or [email protected] to discuss their rights and options. The firm said it would handle any matter on a contingent fee basis.